Blog

Skin Cancer Foundation: A form of Vitamin B3 may reduce skin cancer

Australian researchers recently released a study abstract revealing that Nicotinamide, a form of vitamin B3, significantly reduces the incidence of nonmelanoma skin cancers among people who have had a previous basal cell carcinoma or squamous cell carcinoma. The researchers conducted a year-long study of 386 people, who averaged 66 years old. Half of the people in the study took 500 milligrams of Nicotinamide (Vitamin B3) twice a day and the other half were put on a placebo. The researchers found that people who took vitamin B3 twice a day cut their chances of developing new skin cancers by 23 percent. Read more… Read more

Comments are closed.

Skin Vein